Alivus Life Sciences Statistics
Total Valuation
NSE:ALIVUS has a market cap or net worth of INR 126.87 billion. The enterprise value is 121.95 billion.
Market Cap | 126.87B |
Enterprise Value | 121.95B |
Important Dates
The next estimated earnings date is Wednesday, July 23, 2025.
Earnings Date | Jul 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NSE:ALIVUS has 122.63 million shares outstanding. The number of shares has increased by 0.16% in one year.
Current Share Class | 122.63M |
Shares Outstanding | 122.63M |
Shares Change (YoY) | +0.16% |
Shares Change (QoQ) | -0.09% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 7.66% |
Float | 30.73M |
Valuation Ratios
The trailing PE ratio is 26.18 and the forward PE ratio is 23.30.
PE Ratio | 26.18 |
Forward PE | 23.30 |
PS Ratio | 5.32 |
PB Ratio | 4.50 |
P/TBV Ratio | 4.54 |
P/FCF Ratio | 56.30 |
P/OCF Ratio | 32.40 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.87, with an EV/FCF ratio of 54.12.
EV / Earnings | 25.11 |
EV / Sales | 5.11 |
EV / EBITDA | 17.87 |
EV / EBIT | 19.61 |
EV / FCF | 54.12 |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.97 |
Quick Ratio | 3.23 |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.08 |
Debt / FCF | 0.25 |
Interest Coverage | 257.65 |
Financial Efficiency
Return on equity (ROE) is 18.86% and return on invested capital (ROIC) is 14.88%.
Return on Equity (ROE) | 18.86% |
Return on Assets (ROA) | 12.42% |
Return on Invested Capital (ROIC) | 14.88% |
Return on Capital Employed (ROCE) | 21.15% |
Revenue Per Employee | 11.85M |
Profits Per Employee | 2.41M |
Employee Count | 2,014 |
Asset Turnover | 0.76 |
Inventory Turnover | 1.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.19 |
52-Week Price Change | n/a |
50-Day Moving Average | 1,067.62 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 40.49 |
Average Volume (20 Days) | 89,654 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ALIVUS had revenue of INR 23.87 billion and earned 4.86 billion in profits. Earnings per share was 39.52.
Revenue | 23.87B |
Gross Profit | 13.06B |
Operating Income | 6.22B |
Pretax Income | 6.54B |
Net Income | 4.86B |
EBITDA | 6.83B |
EBIT | 6.22B |
Earnings Per Share (EPS) | 39.52 |
Balance Sheet
The company has 5.49 billion in cash and 566.06 million in debt, giving a net cash position of 4.92 billion or 40.14 per share.
Cash & Cash Equivalents | 5.49B |
Total Debt | 566.06M |
Net Cash | 4.92B |
Net Cash Per Share | 40.14 |
Equity (Book Value) | 28.17B |
Book Value Per Share | 229.77 |
Working Capital | 18.65B |
Cash Flow
In the last 12 months, operating cash flow was 3.92 billion and capital expenditures -1.66 billion, giving a free cash flow of 2.25 billion.
Operating Cash Flow | 3.92B |
Capital Expenditures | -1.66B |
Free Cash Flow | 2.25B |
FCF Per Share | 18.38 |
Margins
Gross margin is 54.72%, with operating and profit margins of 26.06% and 20.35%.
Gross Margin | 54.72% |
Operating Margin | 26.06% |
Pretax Margin | 27.41% |
Profit Margin | 20.35% |
EBITDA Margin | 28.60% |
EBIT Margin | 26.06% |
FCF Margin | 9.44% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.48%.
Dividend Per Share | 5.00 |
Dividend Yield | 0.48% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.16% |
Shareholder Yield | 0.32% |
Earnings Yield | 3.83% |
FCF Yield | 1.78% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |